CD44 and metabolic dysfunction-associated steatohepatitis: Of particular relevance, data published by Malehmir and colleagues, using both human samples and murine models, demonstrated that HA-CD44 signaling promotes platelet recruitment and aggregation in nonalcoholic steatohepatitis (NASH), thereby fostering a tumor-initiating niche.